Arden, M. A. http://orcid.org/0000-0002-6199-717X
Hutchings, M.
Whelan, P.
Drabble, S. J.
Beever, D.
Bradley, J. M.
Hind, D.
Ainsworth, J.
Maguire, C.
Cantrill, H.
O’Cathain, A.
Wildman, M.
Funding for this research was provided by:
Programme Grants for Applied Research (RP-PG-1212-20015)
Article History
Received: 20 February 2020
Accepted: 30 November 2020
First Online: 4 January 2021
Ethics approval and consent to participate
: Ethical approval was gained for all studies: from the Yorkshire and Humber ethics committee [REC reference 15/YH/0332] and West of Scotland ethics committee [REC reference 15/WS/0089]. All participants gave written informed consent.
: Not applicable
: Martin Wildman received funding from Zambon and support from Philips Respironics for the early development work. This has not had any direct influence on the study reported here. Martin Wildman has worked with Pari to carry out studies using the eTrack. This has not had any direct influence on the study reported here. The University of Manchester software team received funding from Pari to create a medication reporting component within the CFHealthHub software. This has not had any direct influence on the study reported here.The other authors declare that they have no competing interests.